Oncternal Therapeutics, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
Oncternal Therapeutics will be delisted from the Nasdaq Stock Market after announcing a complete workforce reduction and exploring strategic alternatives.
Oncternal Therapeutics is reducing its workforce and exploring strategic alternatives, incurring approximately $2.4 million in related charges.